Research output per year
Research output per year
Personal profile
About
Related documents
Education/Academic qualification
Fellowship Program - Hematology/Oncology, University of Oklahoma Health Sciences Center
2002 → 2004
Residency Program - Internal Medicine, University of Oklahoma Health Sciences Center
1996 → 1999
School of Public Health, Public Health, M.P.H., Harvard University
1992 → 1993
Bangalore Medical College, Bachelor of Medicine, Bachelor of Surgery, MBBS, Bangalore University
1986 → 1991
External positions
Medical Oncologist, Advanced Medical Specialties
Jan 1 2004 → Jan 1 2014
Assistant Professor, University of Oklahoma
Jan 1 1999 → Jan 1 2002
Vascular Medicine Section Research Assistant, University of Oklahoma Health Sciences Center
Jan 1 1994 → Jan 1 1996
Global AIDS Policy Coalition Research Assistant, Harvard University
Jan 1 1992 → Jan 1 1993
Assistant Professor, COM Humanities Health and Society, Florida International University
Disciplines
- Medicine and Health Sciences
- Hematology
- Oncology
-
Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors
Villalona-Calero, M. A., Diaz, J. P., Duan, W., Diaz, Z., Schroeder, E. D., Aparo, S., Gatcliffe, T., Albrecht, F., Venkatappa, S., Guardiola, V., Garrido, S., Rubens, M., DeZarraga, F. & Vuong, H., Dec 2022, In: Biomarker Research. 10, 1, 39.Research output: Contribution to journal › Article › peer-review
Open Access -
Managing Your Cancer During this Covid-19 Crisis
Venkatappa, S. A., Apr 2020Research output: Non-textual form › Digital or Visual Products
-
Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).
Villalona-Calero, M. A., Diaz, J. P., Diaz, Z., Duan, W., Schroeder, E. D., Aparo, S., Gatcliffe, T. A., Alonso, A. P., Cuitiva, S., Albrecht, F., Venkatappa, S. A., Guardiola, V., Troner, M. B., Garrido, S. M., Walker, G., Rubens, M., De Zarraga, F. I. & Vuong, H., May 20 2019, In: Journal of Clinical Oncology. 37Research output: Contribution to journal › Article › peer-review
-
Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).
Villalona-Calero, M. A., Diaz, J. P., Diaz, Z., Duan, W., Schroeder, E. D., Aparo, S., Gatcliffe, T. A., Alonso, A. P., Cuitiva, S., Albrecht, F., Venkatappa, S. A., Guardiola, V., Troner, M. B., Garrido, S. M., Walker, G., Rubens, M., De Zarraga, F. I. & Vuong, H., May 20 2019.Research output: Contribution to conference › Presentation
-
Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM).
Villalona-Calero, M. A., Diaz, J. P., Diaz, Z., Duan, W., Schroeder, E. D., Aparo, S., Gatcliffe, T. A., Alonso, A. P., Cuitiva, S., Albrecht, F., Venkatappa, S. A., Guardiola, V., Troner, M. B., Garrido, S. M., Walker, G., Rubens, M., De Zarraga, F. I. & Vuong, H., May 20 2019.Research output: Contribution to conference › Presentation